Total Payments
$5,695
2024 Payments
$85.55
Companies
26
Transactions
67
Medicare Patients
525
Medicare Billing
$60,679
Payment Breakdown by Category
Consulting$3,425 (60.1%)
Food & Beverage$2,052 (36.0%)
Gifts$194.23 (3.4%)
Education$23.24 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,425 | 1 | 60.1% |
| Food and Beverage | $2,052 | 63 | 36.0% |
| Gift | $194.23 | 1 | 3.4% |
| Education | $23.24 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,857 | 8 | $0 (2023) |
| Intuitive Surgical, Inc. | $462.87 | 4 | $0 (2022) |
| GlaxoSmithKline, LLC. | $314.24 | 5 | $0 (2024) |
| Genentech USA, Inc. | $113.68 | 2 | $0 (2019) |
| Amgen Inc. | $105.33 | 7 | $0 (2020) |
| IsoRay, Inc | $85.66 | 1 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $79.01 | 4 | $0 (2018) |
| Karyopharm Therapeutics Inc. | $76.86 | 1 | $0 (2022) |
| Merck Sharp & Dohme LLC | $66.17 | 4 | $0 (2024) |
| TerSera Therapeutics LLC | $65.89 | 5 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85.55 | 3 | GlaxoSmithKline, LLC. ($60.09) |
| 2023 | $3,550 | 2 | AstraZeneca Pharmaceuticals LP ($3,425) |
| 2022 | $168.98 | 3 | Karyopharm Therapeutics Inc. ($76.86) |
| 2021 | $215.00 | 2 | GlaxoSmithKline, LLC. ($115.00) |
| 2020 | $222.70 | 3 | Intuitive Surgical, Inc. ($194.23) |
| 2019 | $671.02 | 19 | AstraZeneca Pharmaceuticals LP ($220.00) |
| 2018 | $572.13 | 28 | AstraZeneca Pharmaceuticals LP ($96.73) |
| 2017 | $209.54 | 7 | Intuitive Surgical, Inc. ($128.21) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/20/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $25.46 | General |
| Category: ONCOLOGY | ||||||
| 03/16/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $39.99 | General |
| 10/19/2023 | GlaxoSmithKline, LLC. | JEMPERLI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ONCOLOGY | ||||||
| 03/16/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $3,425.00 | General |
| 04/26/2022 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $48.75 | General |
| Category: SURGERY | ||||||
| 03/21/2022 | Seagen Inc. | TIVDAK (Biological) | Food and Beverage | In-kind items and services | $43.37 | General |
| Category: Oncology | ||||||
| 03/10/2022 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $76.86 | General |
| Category: Oncology | ||||||
| 12/01/2021 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $115.00 | General |
| Category: ONCOLOGY | ||||||
| 05/19/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Oncology | ||||||
| 05/01/2020 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Gift | In-kind items and services | $194.23 | General |
| Category: SURGERY | ||||||
| 03/04/2020 | Amgen Inc. | Prolia (Biological), XGEVA | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Bone Health | ||||||
| 01/06/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2019 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $21.59 | General |
| Category: Oncology | ||||||
| 11/19/2019 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $98.84 | General |
| 10/25/2019 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $91.68 | General |
| Category: SURGERY | ||||||
| 08/21/2019 | TerSera Therapeutics LLC | ZOLADEX (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: ONCOLOGY | ||||||
| 05/23/2019 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $94.49 | General |
| Category: Oncology | ||||||
| 05/20/2019 | Fortovia Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $9.94 | General |
| 05/06/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: ONCOLOGY | ||||||
| 04/30/2019 | BAXTER HEALTHCARE | TISSEEL (Biological) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Surgical Care | ||||||
| 04/29/2019 | Lilly USA, LLC | ALIMTA (Drug), CYRAMZA, VERZENIO | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Oncology | ||||||
| 04/09/2019 | Bayer HealthCare Pharmaceuticals Inc. | Stivarga (Drug), Nexavar | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Oncology | ||||||
| 03/21/2019 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 136 | 180 | $37,587 | $14,320 |
| 2022 | 6 | 154 | 228 | $56,107 | $25,294 |
| 2021 | 3 | 127 | 188 | $23,624 | $10,853 |
| 2020 | 4 | 108 | 144 | $22,862 | $10,211 |
Total Patients
525
Total Services
740
Medicare Billing
$60,679
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 124 | $18,853 | $7,316 | 38.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 44 | 44 | $17,642 | $6,663 | 37.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 12 | $1,092 | $340.64 | 31.2% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 12 | 12 | $18,372 | $8,288 | 45.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 94 | $13,054 | $5,994 | 45.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 43 | $8,424 | $4,127 | 49.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $8,142 | $3,393 | 41.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $4,703 | $1,976 | 42.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 35 | 41 | $3,412 | $1,516 | 44.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 62 | 112 | $8,960 | $4,513 | 50.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $8,790 | $3,981 | 45.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 45 | $5,874 | $2,360 | 40.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 59 | 95 | $11,058 | $4,932 | 44.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 25 | 25 | $7,930 | $3,521 | 44.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $2,870 | $1,330 | 46.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 13 | $1,004 | $428.40 | 42.7% |
About Dr. Gregory Sutton, MD
Dr. Gregory Sutton, MD is a Gynecologic Oncology healthcare provider based in Saginaw, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568409373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Sutton, MD has received a total of $5,695 in payments from pharmaceutical and medical device companies, with $85.55 received in 2024. These payments were reported across 67 transactions from 26 companies. The most common payment nature is "Consulting Fee" ($3,425).
As a Medicare-enrolled provider, Sutton has provided services to 525 Medicare beneficiaries, totaling 740 services with total Medicare billing of $60,679. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology
- Location Saginaw, MI
- Active Since 06/01/2006
- Last Updated 03/26/2021
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1568409373
Products in Payments
- Da Vinci Surgical System (Device) $462.87
- LYNPARZA (Drug) $320.00
- ZEJULA (Drug) $177.53
- JEMPERLI (Biological) $145.10
- Brachytherapy Source (Device) $85.66
- XPOVIO (Drug) $76.86
- KEYTRUDA (Biological) $66.17
- ZOLADEX (Drug) $65.89
- Stivarga (Drug) $44.61
- PROMACTA (Drug) $44.14
- TIVDAK (Biological) $43.37
- Erleada (Drug) $41.27
- Neulasta (Biological) $40.21
- Abraxane (Drug) $38.94
- TASIGNA (Drug) $34.87
- Blincyto (Biological) $25.60
- Nerlynx (Drug) $24.88
- ELITEK (Drug) $24.57
- GILOTRIF (Drug) $23.15
- Lonsurf (Drug) $22.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.